RNAs of influenza virus recombinants derived from parents of known virulence for man
- PMID: 889441
- DOI: 10.1007/BF01314375
RNAs of influenza virus recombinants derived from parents of known virulence for man
Abstract
Extensive use of recombinants made from A/PR/8/34 (H0N1) and wild, virulent H3N2 viruses as live influenza vaccines has provided a number of viruses of defined virulence for man. Clinical symptoms produced by these strains have ranged from febrile influenza to local coryzal symptoms or nil. A study was therefore made of the extent to which the PR8 genome had been incorporated into that of a number of the recombinants. By RNA--RNA hybridization it seemed that recombinants which had 55 per cent of greater homology with the PR8 parent were likely to conform an acceptable standard of attenuation. Those with lesser homology were frequently, but not always, clinically virulent. The technique seemed potentially useful, therefore, for screening PR8 live vaccine recombinants in vitro before giving them to volunteers.
Similar articles
-
Trials of live influenza A recombinants in man during natural antigenic change in 1971-1976.Med Microbiol Immunol. 1978 Nov 17;166(1-4):91-8. doi: 10.1007/BF02121138. Med Microbiol Immunol. 1978. PMID: 723793
-
RNA-RNA hybridization between influenza viruses.Dev Biol Stand. 1977 Jun 1-3;39:11-14. Dev Biol Stand. 1977. PMID: 604092
-
Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle.Acta Virol. 1980 Jun;24(4):273-8. Acta Virol. 1980. PMID: 6106378
-
Recombinants of influenza virus type B as potential live vaccine candidates: RNA characterization and evaluation in man.J Hyg (Lond). 1981 Aug;87(1):43-52. doi: 10.1017/s0022172400069229. J Hyg (Lond). 1981. PMID: 7019320 Free PMC article. Clinical Trial.
-
[Development of influenza vaccines against newly emerging A/H5N1 virus].Nihon Rinsho. 2000 Jan;58(1):255-64. Nihon Rinsho. 2000. PMID: 10885322 Review. Japanese.
Cited by
-
Chapter 7 Orthomyxovirus infections.Perspect Med Virol. 1985;1:255-343. doi: 10.1016/S0168-7069(08)70015-6. Epub 2008 May 29. Perspect Med Virol. 1985. PMID: 32287580 Free PMC article.
-
Gene constellation of live influenza A vaccines.Arch Virol. 1980;64(2):171-3. doi: 10.1007/BF01318021. Arch Virol. 1980. PMID: 7387405
-
Comparison of the protective efficacies of the live vaccine RIT 4025 and an inactivated vaccine against a natural heterologous A/Victoria/3/75 infection.J Hyg (Lond). 1979 Oct;83(2):221-9. doi: 10.1017/s0022172400026000. J Hyg (Lond). 1979. PMID: 385764 Free PMC article. Clinical Trial.
-
Trials of live influenza A recombinants in man during natural antigenic change in 1971-1976.Med Microbiol Immunol. 1978 Nov 17;166(1-4):91-8. doi: 10.1007/BF02121138. Med Microbiol Immunol. 1978. PMID: 723793
-
Molecular determinants within the surface proteins involved in the pathogenicity of H5N1 influenza viruses in chickens.J Virol. 2004 Sep;78(18):9954-64. doi: 10.1128/JVI.78.18.9954-9964.2004. J Virol. 2004. PMID: 15331729 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials